MXCT
MXCT
NASDAQ · Life Sciences Tools & Services

Maxcyte Inc

$1.08
+0.04 (+3.85%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 10 77%
Hold 3 23%
Sell 0 0%
Price Target
Analyst Price Target +696.3% upside
Low Target $6.90
Average Target $8.60
High Target $12.01
Current Price $1.08
Current
$1.08
Target
$8.60
$6.90 $8.60 avg $12.01
Scenario Analysis
Bear Case
$6.90
538.9%
Low target
Base Case
$8.60
+696.3%
Avg target
Bull Case
$12.01
+1,012.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.40
-55.0% from high
52-Week Low
$0.64
+68.0% from low
Target vs 52W High
$8.60
+258.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 88% $369.21 -17.3%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -5.3%
WAT
Waters Corp
Buy 28 57% $189.60 -43.1%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -41.5%
IQV
Iqvia Holdings Inc
Strong Buy 31 87% $82.96 -52.1%
ILMN
Illumina Inc
Hold 28 54% $169.36 +19.5%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -55.0%
MTD
Mettler-Toledo International
Hold 21 48% $170.43 -84.2%